Valuation: Teleflex Incorporated

Market Cap 5.31B 26.47B 4.73B 4.41B 4.01B 7.56B 511B 7.61B 53.29B 20.73B 261B 19.92B 19.49B 838B P/E 2026 *
33.5x
P/E 2027 * 15.4x
Enterprise Value 6.69B 33.35B 5.96B 5.56B 5.06B 9.52B 644B 9.59B 67.14B 26.12B 329B 25.1B 24.55B 1,056B EV / Sales 2026 *
2.95x
EV / Sales 2027 * 2.65x
Free-Float
87.35%
Yield 2026 *
1.08%
Yield 2027 * 1.1%
1 day+2.87%
3 months+5.82%
6 months+12.55%
Current year+3.68%
Current year 52.65
Extreme 52.65
74.99
1 year 52.65
Extreme 52.65
74.99
3 years 52.65
Extreme 52.65
122.56
5 years 52.65
Extreme 52.65
174
10 years 52.65
Extreme 52.65
221.72
Manager TitleAgeSince
Chief Executive Officer - 2026-06-07
Director of Finance/CFO - 2025-04-01
Compliance Officer - 2017-12-31
Director TitleAgeSince
Director/Board Member 66 2008-12-31
Director/Board Member 72 2015-04-30
Director/Board Member 70 2016-09-12
Change 5-day change 1-year change 3-year change Capi.($)
+2.87%-.--% - - 5.26B
+2.67%-0.87%-25.63%+4.05% 169B
+1.84%-1.71%-9.96%+15.52% 110B
+3.55%+3.60%-23.02%+7.71% 106B
+1.19%-1.10%-48.90%-11.35% 73.87B
+1.90%+3.66%+4.02%+70.20% 58.98B
+1.39%+6.95%+10.08%+66.27% 51.28B
+2.19%-1.72%-6.68%-30.79% 48.16B
+1.67%-0.38%-16.50%+22.43% 40.84B
+1.80%+0.25%+29.60%+3.45% 32.21B
Average +2.11%+0.52%-9.66%+16.39% 76.69B
Weighted average by Cap. +2.22%+0.35%-15.58%+13.70%

Financials

2026 *2027 *
Net sales 2.27B 11.31B 2.02B 1.89B 1.72B 3.23B 218B 3.25B 22.78B 8.86B 111B 8.51B 8.33B 358B 2.37B 11.8B 2.11B 1.97B 1.79B 3.37B 228B 3.4B 23.76B 9.24B 116B 8.88B 8.69B 374B
Net income 121M 603M 108M 101M 91.46M 172M 11.65B 174M 1.21B 472M 5.94B 454M 444M 19.11B 171M 853M 153M 142M 129M 244M 16.47B 245M 1.72B 668M 8.41B 642M 628M 27.02B
Net Debt 1.38B 6.88B 1.23B 1.15B 1.04B 1.96B 133B 1.98B 13.84B 5.39B 67.75B 5.17B 5.06B 218B 960M 4.79B 856M 798M 726M 1.37B 92.42B 1.38B 9.64B 3.75B 47.17B 3.6B 3.52B 152B
Logo Teleflex Incorporated
Teleflex Incorporated is a global provider of medical technologies. The Company offers a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, and vascular access. It primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates in three segments: the Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Its vascular access product portfolio includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous (bone access) systems. Its interventional product offerings consist of a portfolio of the MANTA Vascular Closure device, Arrow OnControl powered bone biopsy system, GuideLiner, Turnpike and TrapLiner catheters.
Employees
15,500
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
125.24USD
Average target price
154.73USD
Spread / Average Target
+23.54%

Quarterly revenue - Rate of surprise